fda tirzepatide injection shortage resolved october 2 2024 says years-long is resolved, will give limited leeway to compounders US FDA says Lilly's weight-loss

Diving headfirst into the GLP-1 space, AstraZeneca is seeking to join rival drugmakers by maximizing opportunities around treating diabetes and weight loss

They come with their own stomach and kidney considerations, but the acetaminophen math stays clean

By effectively targeting these pathways, semaglutide helps to reduce overall appetite and caloric intake, making it a highly effective component of a comprehensive weight management plan

Lab facilities GLP regulations require that nonclinical studies be carried out in testing facilities of suitable size, design, and construction

Without a strong behavioral foundation, the withdrawal of medication can magnify stress and lower self-efficacy